ArticleBlood neoplasia2026

Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference.

Marta Lustig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.